GC
CELG

Gratry & Company’s Celgene Corp CELG Stock Holding History

Gratry & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,955
Closed -$285K – 100
2017
Q3 		$285K Hold
1,955
– – 0.35% 62
2017
Q2 		$254K Hold
1,955
– – 0.31% 75
2017
Q1 		$243K Sell
1,955
-164
-8% -$19.6K 0.3% 74
2016
Q4 		$245K Sell
2,119
-75
-3% -$8.35K 0.22% 69
2016
Q3 		$229K Sell
2,194
-31
-1% -$3.35K 0.18% 66
2016
Q2 		$219K Hold
2,225
– – 0.17% 62
2016
Q1 		$223K Sell
2,225
-1,395
-39% -$144K 0.16% 64
2015
Q4 		$434K Sell
3,620
-1,570
-30% -$182K 0.28% 42
2015
Q3 		$561K Buy
5,190
+90
+2% +$11.2K 0.34% 39
2015
Q2 		$590K Hold
5,100
– – 0.31% 40
2015
Q1 		$588K Buy
+5,100
New +$609K 0.32% 45

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gratry & Company's CELG Position: Q4 2017 in Review

Gratry & Company sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,955 shares — an estimated $285K sold.

Gratry & Company first reported a position in CELG in Q1 2015 and held it in 11 quarters. The position peaked at $590K in Q2 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Gratry & Company reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Gratry & Company sold 1,955 Celgene Corp shares in Q4 2017, an estimated $285K.
  • Gratry & Company first reported a position in Celgene Corp in Q1 2015 and held it in 11 quarters.
  • Gratry & Company's Celgene Corp position peaked at $590K in Q2 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Gratry & Company's 13F filing for Q4 2017, filed 5 Feb 2018.